ALHC Quote, Financials, Valuation and Earnings

Centene has a net margin of -0.98% compared to Alignment Healthcare's net margin of 2.81%. Alignment Healthcare's return on equity of -77.81% beat Centene's return on equity of 12.65%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 30.44%. On the other hand Centene has an analysts' consensus of $76.50 which suggests that it could grow by 43.26%. Given that Centene has higher upside potential than Alignment Healthcare, analysts believe Centene is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene has a beta of 0.453, suggesting its less volatile than the S&P 500 by 54.716%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than Centene quarterly revenues of $46.6B. Alignment Healthcare's net income of -$9.1M is lower than Centene's net income of $1.3B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Centene's PE ratio is 7.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.89x versus 0.16x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of -0.98% compared to Alignment Healthcare's net margin of 4.47%. Alignment Healthcare's return on equity of -77.81% beat Elevance Health's return on equity of 14.03%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 30.44%. On the other hand Elevance Health has an analysts' consensus of $500.75 which suggests that it could grow by 34.46%. Given that Elevance Health has higher upside potential than Alignment Healthcare, analysts believe Elevance Health is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.603, suggesting its less volatile than the S&P 500 by 39.674%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.79% to investors and pays a quarterly dividend of $1.71 per share. Alignment Healthcare pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than Elevance Health quarterly revenues of $48.9B. Alignment Healthcare's net income of -$9.1M is lower than Elevance Health's net income of $2.2B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Elevance Health's PE ratio is 14.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.89x versus 0.47x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of -0.98% compared to Alignment Healthcare's net margin of 4.65%. Alignment Healthcare's return on equity of -77.81% beat Progyny's return on equity of 11.16%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 30.44%. On the other hand Progyny has an analysts' consensus of $26.25 which suggests that it could grow by 25.12%. Given that Alignment Healthcare has higher upside potential than Progyny, analysts believe Alignment Healthcare is more attractive than Progyny.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny has a beta of 1.317, suggesting its more volatile than the S&P 500 by 31.741%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are larger than Progyny quarterly revenues of $324M. Alignment Healthcare's net income of -$9.1M is lower than Progyny's net income of $15.1M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Progyny's PE ratio is 36.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.89x versus 1.62x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -0.98% compared to Alignment Healthcare's net margin of 5.74%. Alignment Healthcare's return on equity of -77.81% beat UnitedHealth Group's return on equity of 21.74%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 30.44%. On the other hand UnitedHealth Group has an analysts' consensus of $385.88 which suggests that it could grow by 27.77%. Given that Alignment Healthcare has higher upside potential than UnitedHealth Group, analysts believe Alignment Healthcare is more attractive than UnitedHealth Group.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.442, suggesting its less volatile than the S&P 500 by 55.841%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 2.82% to investors and pays a quarterly dividend of $2.21 per share. Alignment Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Alignment Healthcare's net income of -$9.1M is lower than UnitedHealth Group's net income of $6.3B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 12.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.89x versus 0.68x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.